Oehler, Vivian G <br/><br/>
Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction.  [electronic resource] 

 -  Current hematologic malignancy reports  Sep 2006 
 - 152-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1558-822X 
<br/><br/><label>Standard No.: </label>10.1007/s11899-996-0003-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Biomarkers, Tumor--blood<br/>Bone Marrow Transplantation--methods<br/>Child<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Drug Monitoring<br/>Drug Resistance, Neoplasm--genetics<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood<br/>Multicenter Studies as Topic<br/>Neoplasm, Residual<br/>Piperazines--administration & dosage<br/>Polymerase Chain Reaction--methods<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Recurrence<br/>Sensitivity and Specificity